Cellectar Biosciences, Inc. (CLRB) Deep Dive Video

Name: Cellectar Biosciences, Inc. (CLRB) Deep Dive Video | Flash
Uploaded: 2026-07-09T10:16:33.126Z
Description: Cellectar Biosciences offers a high-risk, high-upside bet that late-stage iopofosine data and upcoming NDA milestones can rerate CLRB far above its distressed $2.70 share price despite heavy dilution and binary regulatory risk.

Cellectar Biosciences, Inc. (CLRB) video thumbnail

Summary

Cellectar Biosciences offers a high-risk, high-upside bet that late-stage iopofosine data and upcoming NDA milestones can rerate CLRB far above its distressed $2.70 share price despite heavy dilution and binary regulatory risk.

View CLRB stock page · Read the CLRB research report

Loading the video player…

Loading Flash…